• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超大重组 AAV 载体基因组完整性的表征。

Characterization of genome integrity for oversized recombinant AAV vector.

机构信息

The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.

出版信息

Mol Ther. 2010 Jan;18(1):87-92. doi: 10.1038/mt.2009.258. Epub 2009 Nov 10.

DOI:10.1038/mt.2009.258
PMID:19904236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2803017/
Abstract

Application of recombinant adeno-associated virus (rAAV) in gene therapy has been limited by its packaging capacity. Recent studies suggested that rAAV could achieve persistent transgene expression beyond 4.7-kb packaging limit. To clarify the mechanism leading to transgene expression from oversized rAAV vector, we constructed a series of rAAV vectors with genomes ranging from 2.9 to 7.2 kb. A plasmid replication origin and an ampicillin-resistant marker were included in the vector to facilitate the recovery of circularized, post-transduction AAV genome. Southern dot-blot analysis and silver staining confirmed that rAAVs could be produced at varying vector size. However, the vector yields decreased approximately tenfold for oversized vectors as compared to regular ones. Alkaline Southern blot hybridization suggested that the packaged genomes for oversized vectors were truncated. In the cells transduced by the above vectors, circularized rAAV monomers could be rescued at 24 hours after infection. Few recovered AAV genomes were >5 kb regardless of the initial vector size. In mice receiving the above vectors, larger circularized rAAV genomes could be recovered for oversized vectors at day 21 after vector administration. Our studies suggested that the partially packaged rAAV sequences may complement each other to restore full expression cassette.

摘要

腺相关病毒(rAAV)在基因治疗中的应用受到其包装能力的限制。最近的研究表明,rAAV 可以实现超过 4.7kb 包装限制的持续转基因表达。为了阐明导致超大 rAAV 载体中转基因表达的机制,我们构建了一系列基因组大小从 2.9 到 7.2kb 的 rAAV 载体。载体中包含一个质粒复制起点和氨苄青霉素抗性标记,以方便回收经转导后的环状 AAV 基因组。Southern 点印迹分析和银染证实 rAAV 可以在不同的载体大小下产生。然而,与常规载体相比,超大载体的载体产量下降了约十倍。碱性 Southern 印迹杂交表明,超大载体包装的基因组发生了截断。在上述载体转导的细胞中,感染后 24 小时即可回收环状 rAAV 单体。无论初始载体大小如何,回收的 AAV 基因组中很少有超过 5kb 的。在接受上述载体的小鼠中,载体给药后第 21 天,超大载体可回收更大的环状 rAAV 基因组。我们的研究表明,部分包装的 rAAV 序列可能相互补充,以恢复完整的表达盒。

相似文献

1
Characterization of genome integrity for oversized recombinant AAV vector.超大重组 AAV 载体基因组完整性的表征。
Mol Ther. 2010 Jan;18(1):87-92. doi: 10.1038/mt.2009.258. Epub 2009 Nov 10.
2
Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection.使用生产细胞系和三重转染法生成的编码人凝血因子VIII的轻度超大型腺相关病毒载体的特性
Hum Gene Ther Methods. 2017 Feb;28(1):23-38. doi: 10.1089/hgtb.2016.124.
3
Effect of genome size on AAV vector packaging.基因组大小对 AAV 载体包装的影响。
Mol Ther. 2010 Jan;18(1):80-6. doi: 10.1038/mt.2009.255. Epub 2009 Nov 10.
4
Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.递送超过腺相关病毒载体承载能力的转基因DNA。
Methods Mol Biol. 2016;1382:21-39. doi: 10.1007/978-1-4939-3271-9_2.
5
Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.2型重组腺相关病毒的复制和包装完全由表达Rep和Cap的1型单纯疱疹病毒扩增子支持。
J Virol. 1997 Nov;71(11):8780-9. doi: 10.1128/JVI.71.11.8780-8789.1997.
6
Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.整合不含所有病毒基因的腺病毒-腺相关病毒杂交载体。
J Virol. 1999 Nov;73(11):9314-24. doi: 10.1128/JVI.73.11.9314-9324.1999.
7
Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.使用合成启动子和串联阵列增强子优化重组腺相关病毒介导的大转基因表达
Hum Gene Ther. 2015 Jun;26(6):334-46. doi: 10.1089/hum.2015.001. Epub 2015 Apr 20.
8
Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.表达超过腺相关病毒衣壳包装能力的转基因。
Hum Gene Ther Methods. 2016 Feb;27(1):1-12. doi: 10.1089/hgtb.2015.140.
9
Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.腺相关病毒血清型的包装能力:更大基因组对感染性及进入后步骤的影响
J Virol. 2005 Aug;79(15):9933-44. doi: 10.1128/JVI.79.15.9933-9944.2005.
10
Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity.自互补重组腺相关病毒载体:包装容量及Rep蛋白在载体纯度中的作用
Hum Gene Ther. 2007 Feb;18(2):171-82. doi: 10.1089/hum.2006.088.

引用本文的文献

1
CRISPR/Cas9 in colorectal cancer: Revolutionizing precision oncology through genome editing and targeted therapeutics.CRISPR/Cas9在结直肠癌中的应用:通过基因组编辑和靶向治疗革新精准肿瘤学。
Iran J Basic Med Sci. 2025;28(10):1279-1300. doi: 10.22038/ijbms.2025.87531.18902.
2
Exploring AAV-Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential.探索腺相关病毒介导的内耳疾病基因治疗:从临床前成功到临床潜力
Adv Sci (Weinh). 2025 Sep;12(33):e08397. doi: 10.1002/advs.202408397. Epub 2025 Jun 20.
3
Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing.使用长读长测序评估不同大小腺相关病毒基因组中包装DNA的负载能力和模式。
Mol Ther Methods Clin Dev. 2025 Apr 19;33(2):101474. doi: 10.1016/j.omtm.2025.101474. eCollection 2025 Jun 12.
4
Genomic Size Is Critical to Guarantee the Genomic Stability of Non-Replicative HSV1 Vectors.基因组大小对于保证非复制型单纯疱疹病毒1型(HSV1)载体的基因组稳定性至关重要。
Int J Mol Sci. 2025 May 21;26(10):4941. doi: 10.3390/ijms26104941.
5
Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia control.使用超大的AAV8载体治疗CPS1缺乏症可实现长期生存并控制血氨水平。
Mol Ther Nucleic Acids. 2025 Feb 3;36(1):102470. doi: 10.1016/j.omtn.2025.102470. eCollection 2025 Mar 11.
6
AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model.腺相关病毒介导的碱基编辑可恢复GJB2显性负性突变相关综合征性听力损失模型中的耳蜗缝隙连接。
JCI Insight. 2025 Mar 10;10(5):e185193. doi: 10.1172/jci.insight.185193.
7
The combination of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables multi-administration to liver.重组腺相关病毒伪脂质纳米颗粒与曲安奈德的组合能够实现对肝脏的多次给药。
Mol Ther Methods Clin Dev. 2024 Dec 17;33(1):101399. doi: 10.1016/j.omtm.2024.101399. eCollection 2025 Mar 13.
8
Nonviral targeted mRNA delivery: principles, progresses, and challenges.非病毒靶向mRNA递送:原理、进展与挑战。
MedComm (2020). 2025 Jan 2;6(1):e70035. doi: 10.1002/mco2.70035. eCollection 2025 Jan.
9
AAV-mediated gene therapies by miniature gene editing tools.通过微型基因编辑工具进行的腺相关病毒介导的基因治疗。
Sci China Life Sci. 2024 Dec;67(12):2540-2553. doi: 10.1007/s11427-023-2608-5. Epub 2024 Sep 27.
10
The ABCs of Stargardt disease: the latest advances in precision medicine.斯塔加特病的基础知识:精准医学的最新进展
Cell Biosci. 2024 Jul 26;14(1):98. doi: 10.1186/s13578-024-01272-y.

本文引用的文献

1
Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium.通过定向进化生成新型 AAV 变体,以改善 CFTR 递送至人纤毛气道上皮的效果。
Mol Ther. 2009 Dec;17(12):2067-77. doi: 10.1038/mt.2009.155. Epub 2009 Jul 14.
2
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.腺相关病毒1型介导的基因向人体骨骼肌的转移导致衣壳特异性T细胞的剂量依赖性激活。
Blood. 2009 Sep 3;114(10):2077-86. doi: 10.1182/blood-2008-07-167510. Epub 2009 Jun 8.
3
Enhanced factor VIII heavy chain for gene therapy of hemophilia A.用于A型血友病基因治疗的增强型凝血因子VIII重链
Mol Ther. 2009 Mar;17(3):417-24. doi: 10.1038/mt.2008.292. Epub 2009 Jan 6.
4
Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.α-肌聚糖过度表达缺乏毒性支持肢带型肌营养不良症2D型的临床基因转移试验。
Neurology. 2008 Jul 22;71(4):240-7. doi: 10.1212/01.wnl.0000306309.85301.e2. Epub 2008 Jun 4.
5
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.一项针对心力衰竭患者冠状动脉内注射AAV1/SERCA2a的1/2期试验设计。
J Card Fail. 2008 Jun;14(5):355-67. doi: 10.1016/j.cardfail.2008.02.005. Epub 2008 May 27.
6
Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette.使用包含全长表达盒的腺相关病毒载体对甲型血友病进行完全校正。
Hum Gene Ther. 2008 Jun;19(6):648-54. doi: 10.1089/hum.2007.0182.
7
Safety and efficacy of gene transfer for Leber's congenital amaurosis.基因转移治疗莱伯先天性黑蒙的安全性和有效性。
N Engl J Med. 2008 May 22;358(21):2240-8. doi: 10.1056/NEJMoa0802315. Epub 2008 Apr 27.
8
AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects.腺相关病毒介导的基因转移治疗乙型血友病:问题与前景
Gene Ther. 2008 Jun;15(11):870-5. doi: 10.1038/gt.2008.71. Epub 2008 Apr 24.
9
Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice.腺相关病毒载体中大型基因的血清型依赖性包装可实现对小鼠的有效基因递送。
J Clin Invest. 2008 May;118(5):1955-64. doi: 10.1172/JCI34316.
10
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease.帕金森病hAADC基因治疗I期安全性试验结果。
Neurology. 2008 May 20;70(21):1980-3. doi: 10.1212/01.wnl.0000312381.29287.ff. Epub 2008 Apr 9.